KemPharm announced that it has named Daniel Gallo, Ph.D., as Senior Vice President of Medical Affairs and Advocacy, and Abbi Maher, J.D., as Vice President of Legal Affairs. Both positions are newly created at KemPharm and continue a series of enhancements to the Company’s leadership to support its transformation into a leading rare disease company. Dr. Gallo joins KemPharm from Jaguar Gene Therapy. Maher joins KemPharm from Cytel.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on KMPH:
- KemPharm Enhances Senior Management Team
- KemPharm CEO says positioned for ‘continued growth’
- KemPharm Issues Letter to Shareholders
- KemPharm Partners with the Hypersomnia Foundation to Support Sleep Disorder Research and Advocacy
- KemPharm partners with Hypersomnia Foundation
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue